DE3690028C2 - Verfahren und Testkit für die Analyse einer biologischen Probe auf Antikörper gegen Retroviren - Google Patents

Verfahren und Testkit für die Analyse einer biologischen Probe auf Antikörper gegen Retroviren

Info

Publication number
DE3690028C2
DE3690028C2 DE3690028A DE3690028A DE3690028C2 DE 3690028 C2 DE3690028 C2 DE 3690028C2 DE 3690028 A DE3690028 A DE 3690028A DE 3690028 A DE3690028 A DE 3690028A DE 3690028 C2 DE3690028 C2 DE 3690028C2
Authority
DE
Germany
Prior art keywords
human
retrovirus
antigens
cbl
globulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3690028A
Other languages
German (de)
English (en)
Other versions
DE3690028T (enExample
Inventor
Robin Weiss
Richard Tedder
Cheingsong-Popov Rachanee
Bridget Ferns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Institute of Cancer Research: Royal Cancer Hospital
Original Assignee
The Institute of Cancer Research: Royal Cancer Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858500918A external-priority patent/GB8500918D0/en
Application filed by The Institute of Cancer Research: Royal Cancer Hospital filed Critical The Institute of Cancer Research: Royal Cancer Hospital
Application granted granted Critical
Publication of DE3690028C2 publication Critical patent/DE3690028C2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE3690028A 1985-01-15 1986-01-13 Verfahren und Testkit für die Analyse einer biologischen Probe auf Antikörper gegen Retroviren Expired - Lifetime DE3690028C2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858500918A GB8500918D0 (en) 1985-01-15 1985-01-15 Viral isolates
US75660485A 1985-07-19 1985-07-19
PCT/GB1986/000023 WO1986004423A1 (en) 1985-01-15 1986-01-13 Improvements relating to viral isolates and their use

Publications (1)

Publication Number Publication Date
DE3690028C2 true DE3690028C2 (de) 1995-05-24

Family

ID=26288664

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3690028A Expired - Lifetime DE3690028C2 (de) 1985-01-15 1986-01-13 Verfahren und Testkit für die Analyse einer biologischen Probe auf Antikörper gegen Retroviren
DE19863690028 Pending DE3690028T (enExample) 1985-01-15 1986-01-13

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19863690028 Pending DE3690028T (enExample) 1985-01-15 1986-01-13

Country Status (15)

Country Link
AT (1) ATA900186A (enExample)
AU (1) AU591647B2 (enExample)
BE (1) BE904030A (enExample)
BR (1) BR8604533A (enExample)
CH (1) CH675636A5 (enExample)
DE (2) DE3690028C2 (enExample)
DK (1) DK437386A (enExample)
FI (1) FI863704L (enExample)
FR (1) FR2576107B1 (enExample)
GB (1) GB2179449B (enExample)
HU (1) HU204929B (enExample)
IT (1) IT1191841B (enExample)
NL (1) NL8620004A (enExample)
SE (1) SE8603803D0 (enExample)
WO (1) WO1986004423A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500918D0 (en) * 1985-01-15 1985-02-20 Cancer Res Inst Viral isolates
ATE54757T1 (de) * 1985-02-05 1990-08-15 Us Commerce Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
JPS62500049A (ja) * 1985-02-26 1987-01-08 アメリカ合衆国 ヒトｔ↓−細胞白血病ウイルスタイプ３の検出
US4748110A (en) * 1985-09-25 1988-05-31 Abbott Laboratories Immunoassay for HTLV-III antigens
US5364933A (en) * 1986-03-03 1994-11-15 Institut Pasteur Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US6514691B1 (en) 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
CA1278259C (en) * 1986-02-26 1990-12-27 William C. Saxinger Competitive elisa for the detection of antibodies
US4904581A (en) * 1986-05-06 1990-02-27 Epitope, Inc. Method of detecting AIDS virus infection
SE8701765L (sv) * 1987-04-28 1988-10-29 Statens Bakteriologiska Lab Analysmetod och medel foer denna
IE63455B1 (en) * 1987-09-04 1995-04-19 Int Murex Tech Corp Immunoassay and biological constructs for use therein
US5115098A (en) * 1990-02-28 1992-05-19 President And Fellows Of Harvard College End-blocked peptides inhibiting binding capacity of gp120

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016687A (en) * 1978-03-20 1979-09-26 Abbott Lab Sugar Coated Reagents for Solid Phase Immunoassay
EP0136798A2 (en) * 1983-08-25 1985-04-10 Biotech Research Laboratories Inc. Titre plate and assay kit for detection of antibodies in human serum and their production and use
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652599A (en) * 1984-04-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
NZ228756A (en) * 1984-04-23 1990-10-26 Us Health Detection of hiv antigen using competition immune assay or western blot assay
AU580425B2 (en) * 1985-05-24 1989-01-12 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Competitive elisa for the detection of antibodies

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016687A (en) * 1978-03-20 1979-09-26 Abbott Lab Sugar Coated Reagents for Solid Phase Immunoassay
EP0136798A2 (en) * 1983-08-25 1985-04-10 Biotech Research Laboratories Inc. Titre plate and assay kit for detection of antibodies in human serum and their production and use
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FOLEY, G.E. et al.: cancer 18 (1965), 522-529 *
KALYANARAMAN, V.S. et al.: Science 225, 1984, 321-323 *

Also Published As

Publication number Publication date
WO1986004423A1 (en) 1986-07-31
BE904030A (fr) 1986-07-14
FI863704A0 (fi) 1986-09-12
SE8603803L (sv) 1986-09-11
ATA900186A (de) 1993-12-15
HU204929B (en) 1992-02-28
IT1191841B (it) 1988-03-23
IT8619072A0 (it) 1986-01-13
GB2179449B (en) 1988-12-21
GB2179449A (en) 1987-03-04
GB8620371D0 (en) 1986-10-01
AU5238586A (en) 1986-08-13
DE3690028T (enExample) 1987-03-12
DK437386D0 (da) 1986-09-12
NL8620004A (nl) 1986-12-01
FR2576107B1 (fr) 1990-08-31
FI863704A7 (fi) 1986-09-12
FI863704L (fi) 1986-09-12
CH675636A5 (enExample) 1990-10-15
FR2576107A1 (fr) 1986-07-18
AU591647B2 (en) 1989-12-14
DK437386A (da) 1986-09-12
SE8603803D0 (sv) 1986-09-11
BR8604533A (pt) 1987-07-14
HUT41129A (en) 1987-03-30

Similar Documents

Publication Publication Date Title
DE68924878T2 (de) Bestimmung eines felinen pathogen-specifischen Antikörpers und eines felinen pathogenen Antigens in einem Immuntest.
Nara et al. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody
DE69113872T2 (de) Biologisch aktive Reagenzien aus Carboxylgruppenhaltigen Polymerisaten, analytisches Element und Verfahren zur Verwendung.
DE3587969T2 (de) Testverfahren zum nachweis von menschlichem lymphotropischem virus.
DE3853422T2 (de) HIV-3-Retrovirus und seine Verwendung.
EP0770679B2 (de) HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
DE60031548T2 (de) Verfahren zum simultanen nachweis von beiden gliedern eines bindungspaares
EP0023989B1 (de) Enzym-Immuntest zum Nachweis von Erreger-spezifischen Antikörpern und Testsatz für die Durchführung dieses Tests
DE69535601T3 (de) Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
DE69114394T2 (de) Analytisches Element mit biologisch aktivem Reagens und Verfahren zur Verwendung des Reagens.
CH675636A5 (enExample)
DE69008743T2 (de) Extraktionszusammensetzung, Testsatz und deren Verwendung zum Nachweis von Herpes-Simplex-Antigen.
Naqi et al. A monoclonal antibody‐based antigen capture enzyme‐linked immunosorbent assay for identification of infectious bronchitis virus serotypes
RU2082417C1 (ru) Противовирусное средство, вакцина на его основе, способ ее получения, терапевтический агент и способ обнаружения компонентов рнк-вирусов
DE19920704C1 (de) Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
DE69330164T2 (de) Htlv-i/htlv-ii assay und verfahren
EP0265851A2 (de) Verfahren zur Bestimmung von Anti-HIV, Mittel dazu und ihre Verwendung in diesem Verfahren
US4912030A (en) Viral isolates and their use in diagnosis
DE69909897T2 (de) Nachweis von Antikörpern gegen FIV unter Benutzung von ENV/GAG Polypeptiden
CN113788892B (zh) 一种应用抗单纯疱疹病毒单克隆抗体的快速检测试剂盒
DE69028561T2 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
DE69620996T2 (de) Peptidisches reagenz und verfahren zum nachweis einer primärinfektion durch den epstein-barr-virus mittels test der entsprechenden antikörper
WO1991006633A1 (en) Differential diagnostic assay for brucellosis
DE69229284T2 (de) Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden
DE69119445T2 (de) Analysemethode für infektiöse Pferdeanämie-Viren (EIA-Virus)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition